Key facts for J9192
- Billing unit
- 10 MG
- Inj, fluorouracil, 10 mg
- ASP payment limit
- $0.039
- October 2026
- Practitioner MUE
- none published
- CMS publishes no MUE for this code
- OPPS status
- SI N
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS J9192 is the Level II code for Injection, fluorouracil, 10 mg, billed per 10 MG. The Medicare Part B ASP payment limit for October 2026 is $0.039 per billing unit. Under OPPS it carries status indicator N. The 10 mg billing unit means doses are reported in multiples of ten milligrams, with any remainder rounded per contractor policy; mismatched units against the NDC quantity trigger MUE and NDC-unit edits. Other HCPCS codes whose descriptor names fluorouracil: J9191 (Favlyxa from Avyxa Pharma, LLC). The ASP crosswalk maps 28 NDCs to it, sold as Fluorouracil by Sagent Pharmaceuticals, Eugia US LLC, Alembic Pharmaceuticals Inc. No current Billing and Coding Article lists J9192, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J9192 at $0.039 per 10 MG for October 2026, derived from manufacturer average sales price plus 6%. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $0.039 | 10 MG | 20% |
| July 2026 | n/a | 10 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 28 NDCs from 7 labelers to J9192. Report the NDC in the claim's drug segment and bill the number of J9192 units that equals the quantity administered divided by 10 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 25021-0215-98 | Fluorouracil | Sagent Pharmaceuticals | 50 × 1 | 250 |
| 25021-0215-99 | Fluorouracil | Sagent Pharmaceuticals | 100 × 1 | 500 |
| 55150-0498-01 | Fluorouracil | Eugia US LLC | 50 × 1 | 250 |
| 55150-0499-01 | Fluorouracil | Eugia US LLC | 100 × 1 | 500 |
| 62332-0751-50 | Fluorouracil | Alembic Pharmaceuticals Inc. | 50 × 1 | 250 |
| 62332-0779-31 | Fluorouracil | Alembic Pharmaceuticals Inc. | 100 × 1 | 500 |
| 63323-0117-10 | Fluorouracil | FreseniUS Kabi USA, LLC | 10 × 10 | 500 |
| 63323-0117-18 | Fluorouracil | FreseniUS Kabi USA, LLC | 10 × 10 | 500 |
| 63323-0117-19 | Fluorouracil | FreseniUS Kabi USA, LLC | 10 × 10 | 500 |
| 63323-0117-20 | Fluorouracil | FreseniUS Kabi USA, LLC | 20 × 10 | 1000 |
| 63323-0117-51 | Fluorouracil | FreseniUS Kabi USA, LLC | 50 × 1 | 250 |
| 63323-0117-58 | Fluorouracil | FreseniUS Kabi USA, LLC | 50 × 1 | 250 |
| 63323-0117-59 | Fluorouracil | FreseniUS Kabi USA, LLC | 50 × 1 | 250 |
| 63323-0117-61 | Fluorouracil | FreseniUS Kabi USA, LLC | 100 × 1 | 500 |
| 63323-0117-68 | Fluorouracil | FreseniUS Kabi USA, LLC | 100 × 1 | 500 |
| 63323-0117-69 | Fluorouracil | FreseniUS Kabi USA, LLC | 100 × 1 | 500 |
| 68001-0524-30 | Fluorouracil | BluePoint Laboratories | 10 × 10 | 500 |
| 68001-0524-31 | Fluorouracil | BluePoint Laboratories | 20 × 10 | 1000 |
| 68001-0525-27 | Fluorouracil | BluePoint Laboratories | 50 × 1 | 250 |
| 68001-0525-32 | Fluorouracil | BluePoint Laboratories | 100 × 1 | 500 |
| 68001-0627-27 | Fluorouracil | BluePoint Laboratories | 50 × 1 | 250 |
| 68001-0628-32 | Fluorouracil | BluePoint Laboratories | 100 × 1 | 500 |
| 70700-0186-23 | Fluorouracil | Xiromed, LLC | 10 × 10 | 500 |
| 70700-0187-23 | Fluorouracil | Xiromed, LLC | 20 × 10 | 1000 |
| 70700-0188-22 | Fluorouracil | Xiromed, LLC | 50 × 1 | 250 |
| 70700-0189-22 | Fluorouracil | Xiromed, LLC | 100 × 1 | 500 |
| 71288-0154-76 | Fluorouracil | Meitheal Pharmaceuticals Inc. | 100 × 1 | 500 |
| 71288-0170-75 | Fluorouracil | Meitheal Pharmaceuticals Inc. | 50 × 1 | 250 |
Medically Unlikely Edits (MUE)
CMS does not publish an MUE for J9192 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.
MUE for J9192 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J9192 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J9192 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J9192 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists J9192 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Local coverage policies that list J9192
1 active Local Coverage Determination lists J9192 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- External Infusion Pumps, LCD L33794 · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J9192 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Common denials for J9192 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J9192
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- October 2026 ASP movers report: J9192 is priced in the ASP file for the first time in October 2026.
- October 2026 HCPCS update report: J9192 was added in the October 2026 HCPCS update.
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J9192
What does HCPCS code J9192 describe?
J9192 is defined by CMS as "Injection, fluorouracil, 10 mg". Each billing unit represents 10 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J9192 a CPT code?
No. J9192 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as fluorouracil; CPT codes are five-character codes maintained by the AMA. On a Part B claim J9192 reports the drug itself in 10 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for J9192 in October 2026?
The ASP-based payment limit is $0.039 per 10 MG, with 20% beneficiary coinsurance. Commercial payers use their own fee schedules.
Which NDCs map to J9192?
The October 2026 ASP crosswalk lists 28 NDCs from 7 labelers: Fluorouracil (Sagent Pharmaceuticals); Fluorouracil (Eugia US LLC); Fluorouracil (Alembic Pharmaceuticals Inc.); Fluorouracil (FreseniUS Kabi USA, LLC). For example NDC 25021-0215-98 (package size 50) equals 250 billing units of J9192.
Does J9192 have NCCI bundling edits?
No active practitioner PTP pairs list J9192 as a column-1 or column-2 code in the v323r0 release.
J9192 vs J9191: what is the difference?
Both are HCPCS Level II codes whose descriptor names fluorouracil. What sets J9191 apart: Favlyxa from Avyxa Pharma, LLC. J9192 is billed per 10 mg, limit $0.039; J9191 is billed per 10 mg, limit $14.84. Report the code whose descriptor matches the product and setting in the record.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.